Search

Displaying results 3551 - 3560 of 10000 in total
  1. Drug

    Methoxamine

    go.drugbank.com/drugs/DB00723
    ApprovedInvestigationalWithdrawn

    It has little if any direct effect on the central nervous system.

  2. Drug

    Necitumumab

    go.drugbank.com/drugs/DB09559
    ApprovedInvestigationalWithdrawn

    of EGFR. … Binding of necitumumab to EGFR induces receptor internalization and degradation, thereby preventing further activation of EGFR which is beneficial in NSCLC as many patients have increased protein expression

  3. Drug

    Ocrylate

    go.drugbank.com/drugs/DB15086
    Experimental

    Ocrylate is under investigation in clinical trial NCT01918059 (Cosmetic Outcome Study of Lid Laceration Repair With Suture Versus Tissue Adhesive).

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Phenprobamate

    go.drugbank.com/drugs/DB13354
    Investigational

    Mixtures: KUILIL 200 MG/200 MG FİLM TABLET, 40 TABLET, KUIFLEX 200 MG/200 MG FİLM KAPLI TABLET, 40 ADETProducts: GAMAFLEX 400 MG FİLM KAPLI TABLET, 40 ADET
  5. Drug

    Temefos

    go.drugbank.com/drugs/DB12231
    Investigational

    Diphos has been used in trials studying the treatment of Plasmodium Falciparum Malaria.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Emedastine

    go.drugbank.com/drugs/DB01084
    Approved

    Emedastine is an antihistamine used in eye drops to treat allergic conjunctivitis.

  7. Drug

    Calcium lactate gluconate

    go.drugbank.com/drugs/DB13365
    Investigational

    Mixtures: CALCIUM SANDOZ FORTE 300 MG/2940 MG EFERVESAN TABLET, 20 ADET, CALCIUM SANDOZ FORTE 300 MG/2940 MG EFERVESAN TABLET, 10 ADET
  8. Drug

    Ametantrone

    go.drugbank.com/drugs/DB21078
    Experimental

    Ametantrone has a monoisotopic molecular weight of 412.21 Da.

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Copanlisib

    go.drugbank.com/drugs/DB12483
    ApprovedInvestigational

    [A261730] Copanlisib was granted accelerated approval by the FDA in September 2017 for the treatment of follicular lymphoma.[A261725]

  10. Drug

    CX-046684

    go.drugbank.com/drugs/DB19414
    Approved

    It is the active ingredient of the 2024-2025 formulation of Moderna's Spikevax vaccine.[L40074] … CX-046684 is a COVID-19 mRNA vaccine encoding the pre-fusion stabilized Spike glycoprotein (S) of the SARS-CoV-2 Omicron variant lineage KP.2.